Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: Extended 3.5-year follow up from a pooled analysis

  1. Rule, S.
  2. Dreyling, M.
  3. Goy, A.
  4. Hess, G.
  5. Auer, R.
  6. Kahl, B.
  7. Hernández-Rivas, J.-Á.
  8. Qi, K.
  9. Deshpande, S.
  10. Parisi, L.
  11. Wang, M.
Revue:
Haematologica

ISSN: 1592-8721,  0390-6078

Année de publication: 2019

Volumen: 104

Número: 5

Pages: e211-e214

Type: Lettre

DOI: 10.3324/HAEMATOL.2018.205229 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus